With a strong pipeline of drugs in development, a good flow of venture capital investment and seven IPOs, 2010 was an “exceptional” year, says France Biotech

Europe’s biggest-ever private financing round by a biotech doesn’t mean the capital drought is over, says Martin Edwards of Novo Ventures.

Three life sciences and healthcare networking organisations in the UK have made an agreement with MassBio to promote the biotechnology industry in both regions.

Europe needs to expand its focus in biotech beyond healthcare, and apply it as a tool to fight climate change, a conference in Barcelona heard.